
Pineal tetrapeptide developed by Prof. Khavinson — telomerase activator studied in longevity models (human evidence limited to the Khavinson cohort, not independently replicated).
Ranges cited in research literature. Not a usage recommendation. For research use only.
Epithalon (epitalon, epithalone) is a synthetic tetrapeptide — Ala-Glu-Asp-Gly — created by Vladimir Khavinson in St. Petersburg as a defined version of epithalamin, a bovine pineal-gland extract his institute studied from the 1970s. At 390 Da it is one of the smallest peptides in the catalog. Its name and literature are tied to Russian gerontology and to the hypothesis of peptide bioregulators that modulate gene expression.
The finding that made it notable came in 2003: in cultured human fibroblasts, Epithalon induced expression of the catalytic subunit of telomerase, lengthened telomeres and allowed cells to pass the Hayflick division limit. In aged animals (rats, mice, rhesus monkeys) it restored the nocturnal melatonin rhythm, normalized immune parameters and, in some studies, extended median lifespan and reduced the incidence of spontaneous tumors, again with the caveat that almost all the literature comes from the original group.
Human data correspond to epithalamin — the extract, not the tetrapeptide — in open cohorts of elderly people followed for 12 to 15 years by the institute itself, with lower mortality among the treated; there are no independent controlled trials of Epithalon. It is not approved as a drug in any country. Telomerase induction, moreover, is a double-edged sword in cancer biology, which warrants theoretical caution. Renova distributes it for research only.
| Class | Synthetic bioregulator tetrapeptide, analog of epithalamin (pineal extract) |
| Sequence | Ala-Glu-Asp-Gly (AEDG, 4 aa) |
| CAS | 307297-39-8 |
| Origin | Khavinson, St. Petersburg Institute of Bioregulation and Gerontology |
| Main findings | Telomerase induction in human fibroblasts (2003); melatonin restoration in old animals |
| Human evidence | Epithalamin (extract) only, open cohorts from the original group; no controlled trials of the tetrapeptide |
| Regulatory status | Not approved as a drug in any country |
| Properties | Highly water-soluble; acidic peptide (Glu, Asp) with no oxidizable residues |
No. Epithalamin is a bovine pineal-gland extract, a peptide mixture studied since the 1970s; Epithalon is a defined synthetic tetrapeptide (Ala-Glu-Asp-Gly) that Khavinson designed to reproduce its activity. The long-term human data belong to the extract, not the tetrapeptide.
In cultured human fibroblasts, yes: the 2003 study described telomerase expression, telomere lengthening and more cell divisions. It has not been demonstrated in living humans and the finding has not been independently replicated. Moreover, activating telomerase is a mechanism shared with tumor cells, hence the caution.
In aged rats, mice and rhesus monkeys, restoration of the nocturnal melatonin peak, normalization of immune parameters and, in several studies, longer median lifespan and lower incidence of spontaneous tumors. Almost all of that literature comes from Khavinson's group; external replication is minimal.
The original hypothesis is that the peptide regulates pineal-gland function: in old animals whose nocturnal melatonin production has declined, Epithalon partially restored it. It is one of the most consistent effects in animal models, and the one that connects the peptide to circadian rhythms and aging.
Related reading: Epithalon: Telomeres, the Pineal Gland and Longevity · Pinealon: A Peptide Bioregulator for Neuroprotection · HHS and peptide compounding in the U.S.: the October 2026 policy and its 10 conditions
Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.
Your cart is empty